The UK practice of Anti-VEGF therapy for treatment of retinopathy of prematurity

Eye (Lond). 2021 Sep;35(9):2451-2453. doi: 10.1038/s41433-021-01543-9. Epub 2021 Apr 20.
No abstract available

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Bevacizumab / therapeutic use
  • Humans
  • Infant, Newborn
  • Intravitreal Injections
  • Retinopathy of Prematurity* / drug therapy
  • United Kingdom

Substances

  • Angiogenesis Inhibitors
  • Bevacizumab